The NCRI Lung Group has four subgroups that develop research in areas of strategic need.

The Advanced Disease Subgroup, chaired by Professor Fiona Blackhall, develops research into cancer that began in the lung has spread to another part of the body.

Members:

Fiona Blackhall, Clinical Senior Lecturer and Honorary Consultant in Medical Oncology, Christie NHS Foundation Trust (subgroup chair)

Samreen Ahmed, Consultant in Medical Oncology, University Hospitals of Leicester NHS Trust

Lucinda Billingham, Professor of Biostatistics and Director of Statistics, Cancer Research UK Trials Unit, King’s College London (KCL)

Lynn Calman, Associate Professor, University of Southampton
Carles Escriu, Medical Oncology Consultant, Clatterbridge Cancer Centre NHS Foundation Trust

Kevin Franks, Consultant Clinical Oncologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Pippa Labuc, Senior Specialist Occupational Therapist, Guy’s and St Thomas’ NHS Foundation Trust

Jason Lester, Consultant Clinical Oncologist, Velindre NHS Trust

Hannah Lord, Ninewells Hospital Medical School

Gary Middleton, Professor Of Medical Oncology, University of Birmingham

Sanjay Popat, Royal Marsden NHS Foundation Trust

Janette Rawlinson, Consumer Forum & Lung subgroup member, National Cancer Research Institute (NCRI)

Riyaz Shah, Maidstone & Tunbridge Wells NHS Trust

James Spicer, Professor of Experimental Cancer Medicine; Consultant Medical Oncologist, King’s College London (KCL)

Igor Vivanco, Team Leader in Molecular Addictions, Institute of Cancer Research (ICR)

Andrew Wilcock, Macmillan Clinical Reader in Palliative Medicine and Medical Oncology, University of Nottingham

Robin Young

The LOcoRegionalDisease (LORD) Subgroup, chaired by Dr Mary O’Brien, develops research into the recurrence of lung cancer at the same site as the original tumour after a disease-free period.

Members:

Mary O’Brien, Consultant in Medical Oncology, Royal Marsden NHS Foundation Trust (subgroup chair)

Samreen Ahmed, Consultant in Medical Oncology, University Hospitals of Leicester NHS Trust

Richard Booton, King’s College London (KCL)

Lavinia Davey, Senior Clinical Trials Co-ordinator, East Kent Hospitals University NHS Foundation Trust

Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology and Honorary Consultant Clinical Oncologist, Christie NHS Foundation Trust

Fergus Gleeson, Oxford University Hospitals NHS Foundation Trust

Donna Graham, Cork University Hospital

Susan Harden, Consultant in Clinical Oncology, Addenbrooke’s Hospital NHS Foundation Trust

Karen Harrison-Phipps, King’s College London (KCL)

David Landau, Consultant Clinical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust

Fiona McDonald, Consultant Clinical Oncologist, Royal Marsden NHS Foundation Trust

Babu Naidu, King’s College London (KCL)

Sherin Payyappilly, Consultant Histopathologist, Birmingham Heartlands Hospital

Iain Phillips, Clinical Research Fellow, Royal Surrey NHS Foundation Trust

Fiona Taylor, King’s College London (KCL)

David Waller, King’s College London (KCL)

Thida Win, King’s College London (KCL)

The Mesothelioma Subgroup, chaired by Dr Peter Szlosarek, develops research into cancer that develops in the lining that covers the outer surface of the lungs.

Members:

Peter Szlosarek, Clinical Senior Lecturer, King’s College London (KCL) (subgroup chair)

Miranda Ashton, Clinical Research Fellow, University of Glasgow

John Conibear, Barts Health NHS Trust

John Edwards, Consultant Thoracic Surgeon, Sheffield Teaching Hospitals NHS Foundation Trust

Dean Fennell, King’s College London (KCL)

Patricia Fisher, Clinical Director, Sheffield Teaching Hospitals NHS Foundation Trust

Peter Jenkins, Gloucestershire Hospitals NHS Foundation Trust

Mike Lind, King’s College London (KCL)

Robert Rintoul, King’s College London (KCL)

Michael Snee, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Jeremy Steele, King’s College London (KCL)

David Waller, King’s College London (KCL)

The Screening & Early Diagnosis Subgroup, chaired by Dr Phil Crosbie, develops research into lung cancer screening and early diagnosis strategies to improve outcomes by providing care at the earliest possible stage.

Members:

Philip Crosbie, Consultant in Respiratory Medicine and Honorary Senior Lecturer, Manchester University Hospitals NHS Foundation Trust (subgroup chair)

Paul Aveyard, Professor of behavioural medicine, King’s College London (KCL)

David Baldwin, Honorary Professor of Medicine and Consultant Physician, Nottingham University Hospitals NHS Trust

Anand Devaraj, King’s College London (KCL)

John Field, Clinical Professor of Molecular Oncology, King’s College London (KCL)

Frank McCaughan, Honorary Consultant Respiratory Physician & University Lecturer, University of Cambridge

Arjun Nair, Thoracic Imaging Fellow, Imperial College London

Richard Neal, Professor of Primary Care Oncology, University of Leeds

Mick Peake, Clinical Director, University College London Hospitals NHS Foundation Trust (UCLH)

Robert Rintoul, King’s College London (KCL)